Listed

Ocular Therapeutix, Inc

OCULNasdaqCIK 1393434HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$13.5m, Q2 FY2026
Operating income−$82.1m, Q2 FY2026
Net income−$78.8m, Q2 FY2026
Ocular Therapeutix, Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m15.1Revenue, Q3 FY2023, three months to 2023-09-30$15.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure14.8Revenue, Q4 FY2023, three months to 2023-12-31$14.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure14.8Revenue, Q1 FY2024, three months to 2024-03-31$14.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure16.4Revenue, Q2 FY2024, three months to 2024-06-30$16.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure15.4Revenue, Q3 FY2024, three months to 2024-09-30$15.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure17.1Revenue, Q4 FY2024, three months to 2024-12-31$17.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure10.7Revenue, Q1 FY2025, three months to 2025-03-31$10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure13.5Revenue, Q2 FY2025, three months to 2025-06-30$13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure14.5Revenue, Q3 FY2025, three months to 2025-09-30$14.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure13.3Revenue, Q4 FY2025, three months to 2025-12-31$13.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure10.8Revenue, Q1 FY2026, three months to 2026-03-31$10.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure13.5Revenue, Q2 FY2026, three months to 2026-06-30$13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Cost of revenue$m1.4Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure1.4Cost of revenue, Q4 FY2023, three months to 2023-12-31$1.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure1.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure1.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure1.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure1.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure1.3Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure1.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure1.8Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure1.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure1.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure2.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Research and development$m15.0Research and development, Q3 FY2023, three months to 2023-09-30$15.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure16.2Research and development, Q4 FY2023, three months to 2023-12-31$16.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure20.7Research and development, Q1 FY2024, three months to 2024-03-31$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure28.9Research and development, Q2 FY2024, three months to 2024-06-30$28.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure37.1Research and development, Q3 FY2024, three months to 2024-09-30$37.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure41.0Research and development, Q4 FY2024, three months to 2024-12-31$41.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure42.9Research and development, Q1 FY2025, three months to 2025-03-31$42.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure51.1Research and development, Q2 FY2025, three months to 2025-06-30$51.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure52.4Research and development, Q3 FY2025, three months to 2025-09-30$52.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure50.8Research and development, Q4 FY2025, three months to 2025-12-31$50.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure66.2Research and development, Q1 FY2026, three months to 2026-03-31$66.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure54.1Research and development, Q2 FY2026, three months to 2026-06-30$54.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Operating income$m(19.2)Operating income, Q3 FY2023, three months to 2023-09-30−$19.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure(20.1)Operating income, Q4 FY2023, three months to 2023-12-31−$20.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(31.6)Operating income, Q1 FY2024, three months to 2024-03-31−$31.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure(43.6)Operating income, Q2 FY2024, three months to 2024-06-30−$43.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure(46.0)Operating income, Q3 FY2024, three months to 2024-09-30−$46.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure(50.6)Operating income, Q4 FY2024, three months to 2024-12-31−$50.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(63.9)Operating income, Q1 FY2025, three months to 2025-03-31−$63.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(67.6)Operating income, Q2 FY2025, three months to 2025-06-30−$67.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure(68.7)Operating income, Q3 FY2025, three months to 2025-09-30−$68.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure(69.8)Operating income, Q4 FY2025, three months to 2025-12-31−$69.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(93.3)Operating income, Q1 FY2026, three months to 2026-03-31−$93.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(82.1)Operating income, Q2 FY2026, three months to 2026-06-30−$82.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Interest expense$m3.4Interest expense, Q3 FY2023, three months to 2023-09-30$3.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0001558370-23-017989.Report this figure4.2Interest expense, Q4 FY2023, three months to 2023-12-31$4.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-11, accession 0001558370-24-002902. Derived: 12-month figure less the 9-month figure.Report this figure4.1Interest expense, Q1 FY2024, three months to 2024-03-31$4.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-07, accession 0001558370-24-007065.Report this figure3.2Interest expense, Q2 FY2024, three months to 2024-06-30$3.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure3.2Interest expense, Q3 FY2024, three months to 2024-09-30$3.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure3.1Interest expense, Q4 FY2024, three months to 2024-12-31$3.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure3.0Interest expense, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure3.0Interest expense, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure3.0Interest expense, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure2.8Interest expense, Q4 FY2025, three months to 2025-12-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure2.8Interest expense, Q1 FY2026, three months to 2026-03-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure2.8Interest expense, Q2 FY2026, three months to 2026-06-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Net income$m(0.5)Net income, Q3 FY2023, three months to 2023-09-30−$516.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure(29.2)Net income, Q4 FY2023, three months to 2023-12-31−$29.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(64.8)Net income, Q1 FY2024, three months to 2024-03-31−$64.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure(43.8)Net income, Q2 FY2024, three months to 2024-06-30−$43.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure(36.5)Net income, Q3 FY2024, three months to 2024-09-30−$36.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure(48.4)Net income, Q4 FY2024, three months to 2024-12-31−$48.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(64.1)Net income, Q1 FY2025, three months to 2025-03-31−$64.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure(67.8)Net income, Q2 FY2025, three months to 2025-06-30−$67.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure(69.4)Net income, Q3 FY2025, three months to 2025-09-30−$69.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure(64.7)Net income, Q4 FY2025, three months to 2025-12-31−$64.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(88.6)Net income, Q1 FY2026, three months to 2026-03-31−$88.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure(78.8)Net income, Q2 FY2026, three months to 2026-06-30−$78.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Diluted EPS$ per share(0.25)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figurenot reported(0.49)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure(0.26)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure(0.22)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figurenot reported(0.38)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(0.39)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure(0.38)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figurenot reported(0.40)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(0.35)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Basic EPS$ per share(0.01)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figurenot reported(0.49)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure(0.26)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure(0.22)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figurenot reported(0.38)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(0.39)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure(0.38)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figurenot reported(0.40)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(0.35)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure

Balance sheet

Cash and equivalents$598.6m, Q2 FY2026
Shareholders' equity$520.0m, Q2 FY2026
Ocular Therapeutix, Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m111Cash and equivalents, Q3 FY2023, at 2023-09-30$110.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure196Cash and equivalents, FY2023, at 2023-12-31$195.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-05, accession 0001104659-26-010664.Report this figure483Cash and equivalents, Q1 FY2024, at 2024-03-31$482.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure460Cash and equivalents, Q2 FY2024, at 2024-06-30$459.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure427Cash and equivalents, Q3 FY2024, at 2024-09-30$427.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure392Cash and equivalents, FY2024, at 2024-12-31$392.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-05, accession 0001104659-26-010664.Report this figure350Cash and equivalents, Q1 FY2025, at 2025-03-31$349.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure391Cash and equivalents, Q2 FY2025, at 2025-06-30$391.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure345Cash and equivalents, Q3 FY2025, at 2025-09-30$344.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure737Cash and equivalents, FY2025, at 2025-12-31$737.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure667Cash and equivalents, Q1 FY2026, at 2026-03-31$666.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure599Cash and equivalents, Q2 FY2026, at 2026-06-30$598.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Current assets$m141Current assets, Q3 FY2023, at 2023-09-30$141.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017989.Report this figure232Current assets, FY2023, at 2023-12-31$232.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0001558370-25-002000.Report this figure520Current assets, Q1 FY2024, at 2024-03-31$519.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001558370-24-007065.Report this figure499Current assets, Q2 FY2024, at 2024-06-30$498.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001558370-24-011202.Report this figure473Current assets, Q3 FY2024, at 2024-09-30$473.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure441Current assets, FY2024, at 2024-12-31$441.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-05, accession 0001104659-26-010664.Report this figure388Current assets, Q1 FY2025, at 2025-03-31$387.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure433Current assets, Q2 FY2025, at 2025-06-30$433.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure387Current assets, Q3 FY2025, at 2025-09-30$387.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure782Current assets, FY2025, at 2025-12-31$782.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure706Current assets, Q1 FY2026, at 2026-03-31$706.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure644Current assets, Q2 FY2026, at 2026-06-30$644.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Total assets$m162Total assets, Q3 FY2023, at 2023-09-30$162.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001558370-23-017989.Report this figure252Total assets, FY2023, at 2023-12-31$252.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0001558370-25-002000.Report this figure539Total assets, Q1 FY2024, at 2024-03-31$538.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001558370-24-007065.Report this figure517Total assets, Q2 FY2024, at 2024-06-30$517.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001558370-24-011202.Report this figure490Total assets, Q3 FY2024, at 2024-09-30$490.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure458Total assets, FY2024, at 2024-12-31$457.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-05, accession 0001104659-26-010664.Report this figure406Total assets, Q1 FY2025, at 2025-03-31$405.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure451Total assets, Q2 FY2025, at 2025-06-30$451.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure411Total assets, Q3 FY2025, at 2025-09-30$410.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure808Total assets, FY2025, at 2025-12-31$808.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure733Total assets, Q1 FY2026, at 2026-03-31$732.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure671Total assets, Q2 FY2026, at 2026-06-30$671.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Current liabilities$m35.1Current liabilities, Q3 FY2023, at 2023-09-30$35.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017989.Report this figure34.9Current liabilities, FY2023, at 2023-12-31$34.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0001558370-25-002000.Report this figure24.3Current liabilities, Q1 FY2024, at 2024-03-31$24.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001558370-24-007065.Report this figure30.0Current liabilities, Q2 FY2024, at 2024-06-30$30.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001558370-24-011202.Report this figure36.4Current liabilities, Q3 FY2024, at 2024-09-30$36.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure41.4Current liabilities, FY2024, at 2024-12-31$41.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-05, accession 0001104659-26-010664.Report this figure37.9Current liabilities, Q1 FY2025, at 2025-03-31$37.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure42.9Current liabilities, Q2 FY2025, at 2025-06-30$42.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure49.3Current liabilities, Q3 FY2025, at 2025-09-30$49.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure50.8Current liabilities, FY2025, at 2025-12-31$50.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure47.7Current liabilities, Q1 FY2026, at 2026-03-31$47.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure49.2Current liabilities, Q2 FY2026, at 2026-06-30$49.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Total liabilities$m155Total liabilities, Q3 FY2023, at 2023-09-30$154.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001558370-23-017989.Report this figure161Total liabilities, FY2023, at 2023-12-31$160.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0001558370-25-002000.Report this figure131Total liabilities, Q1 FY2024, at 2024-03-31$131.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001558370-24-007065.Report this figure139Total liabilities, Q2 FY2024, at 2024-06-30$139.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001558370-24-011202.Report this figure138Total liabilities, Q3 FY2024, at 2024-09-30$138.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure143Total liabilities, FY2024, at 2024-12-31$142.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-05, accession 0001104659-26-010664.Report this figure140Total liabilities, Q1 FY2025, at 2025-03-31$140.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure145Total liabilities, Q2 FY2025, at 2025-06-30$145.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure153Total liabilities, Q3 FY2025, at 2025-09-30$152.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure154Total liabilities, FY2025, at 2025-12-31$153.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure151Total liabilities, Q1 FY2026, at 2026-03-31$151.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure151Total liabilities, Q2 FY2026, at 2026-06-30$151.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m7.9Shareholders' equity, Q3 FY2023, at 2023-09-30$7.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure91.1Shareholders' equity, FY2023, at 2023-12-31$91.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-05, accession 0001104659-26-010664.Report this figure408Shareholders' equity, Q1 FY2024, at 2024-03-31$408.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure378Shareholders' equity, Q2 FY2024, at 2024-06-30$377.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure352Shareholders' equity, Q3 FY2024, at 2024-09-30$352.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure315Shareholders' equity, FY2024, at 2024-12-31$315.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure266Shareholders' equity, Q1 FY2025, at 2025-03-31$265.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure306Shareholders' equity, Q2 FY2025, at 2025-06-30$305.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure258Shareholders' equity, Q3 FY2025, at 2025-09-30$258.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure654Shareholders' equity, FY2025, at 2025-12-31$654.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure582Shareholders' equity, Q1 FY2026, at 2026-03-31$581.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure520Shareholders' equity, Q2 FY2026, at 2026-06-30$520.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure

Cash flow

Operating cash flow−$67.3m, Q2 FY2026
Capital expenditure$3.4m, Q2 FY2026
Ocular Therapeutix, Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(7.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001558370-24-015613. Derived: 9-month figure less the 6-month figure.Report this figure(22.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$22.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(33.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$33.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure(24.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$24.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001558370-25-010177. Derived: 6-month figure less the 3-month figure.Report this figure(36.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$36.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001104659-25-105919. Derived: 9-month figure less the 6-month figure.Report this figure(39.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$39.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(44.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$44.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(55.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$55.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001104659-26-089450. Derived: 6-month figure less the 3-month figure.Report this figure(50.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$50.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001104659-25-105919. Derived: 9-month figure less the 6-month figure.Report this figure(54.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$54.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure(66.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$66.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure(67.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$67.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001104659-26-089450. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$259.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001558370-24-015613. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$459.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$255.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure0.7Capital expenditure, Q2 FY2024, three months to 2024-06-30$742.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001558370-25-010177. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$89.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001104659-25-105919. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$202.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure1.9Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure1.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001104659-26-089450. Derived: 6-month figure less the 3-month figure.Report this figure6.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$6.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001104659-25-105919. Derived: 9-month figure less the 6-month figure.Report this figure2.8Capital expenditure, Q4 FY2025, three months to 2025-12-31$2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-05, accession 0001104659-26-010664. Derived: 12-month figure less the 9-month figure.Report this figure4.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure3.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001104659-26-089450. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)224.95m, Q2 FY2026
Ocular Therapeutix, Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares77.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3076,975,839 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001558370-23-017989.Report this figure77.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3177,386,287 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001558370-24-007065.Report this figure78.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3078,047,705 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001558370-24-011202.Report this figure85.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3085,142,504 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001558370-24-015613.Report this figure132Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31132,021,945 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001558370-25-006225.Report this figure166Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30165,824,778 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001558370-25-010177.Report this figure167Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30166,992,735 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure169Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31169,396,989 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure173Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30172,594,662 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure184Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30183,919,808 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001104659-25-105919.Report this figure224Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31224,099,410 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001104659-26-055256.Report this figure225Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30224,952,428 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure

Shares outstanding: 219.62mShares outstanding, period not labelled, at 2026-07-31219,615,868 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001104659-26-089450.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.